abrdn UK Equity fund Z AccRegister to Unlock Ratings |
Performance History | 30/04/2018 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | - | 13.0 | -0.8 | |
+/-Cat | - | - | - | -3.1 | - | |
+/-B’mrk | - | - | - | - | - | |
Category: UK Flex-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 11/05/2018 | GBX 142.83 | |
Day Change | 0.19% | |
Morningstar Category™ | UK Flex-Cap Equity | |
IA (formerly IMA) Sector | - | |
ISIN | GB00B13G1D11 | |
Fund Size (Mil) 23/06/2023 | GBP 376.04 | |
Share Class Size (Mil) 29/03/2018 | GBP 0.00 | |
Max Initial Charge | - | |
Ongoing Charge 05/12/2017 | 0.10% |
Investment Objective: abrdn UK Equity fund Z Acc |
To generate growth over the long term (5 years or more) by investing in UK equities (company shares). The fund will invest at least 70% in equities and equity related securities of companies listed, incorporated or domiciled in the UK or companies that derive a significant proportion of their revenues or profits from UK operations or have a significant proportion of their assets there. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Andrew Millington 01/03/2018 | ||
Samantha Brownlee 10/09/2020 | ||
Click here to see others | ||
Inception Date 03/02/2016 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE AllSh +3% TR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for abrdn UK Equity fund Z Acc | 31/05/2023 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 9.61 |
Diageo PLC | Consumer Defensive | 5.69 |
RELX PLC | Industrials | 5.38 |
Unilever PLC | Consumer Defensive | 5.02 |
Prudential PLC | Financial Services | 4.06 |
Increase Decrease New since last portfolio | ||
abrdn UK Equity fund Z Acc |